Rythm
Rythm's revenue rose 95916.7% to $17 million in fiscal 2025. Its operating margin was −187.1%, up from −28,183.3% a year earlier. The diluted share count rose 95.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
Rythm lost money in fiscal 2025: a net loss of $33 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 57 | 11 | 0 | 31 | 32 |
| Debt incl. finance leases | 0 | 0 | 16 | 10 | 81 |
| Net debt (negative means net cash) | −57 | −10 | 16 | −21 | 48 |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | 0.0x | — | — | 0.4x | 6.2x |
| Interest coverage | −29.2x | −56.9x | −171.4x | −32.5x | −7.9x |
| Current ratio | 2.0x | 0.6x | 0.6x | 1.4x | 1.1x |
| Quick ratio | 1.5x | 0.3x | 0.5x | 1.4x | 1.0x |
Cash flow
Projections
Project Rythm's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Rythm shares on the open market, and 3 insiders sold $321,400.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Armon VakiliDirector | Sold | 2,250 | $26.52 | $59,677 | Form 4 |
| Jun 16, 2026 | Max HoltzmanDirector | Sold | 5,000 | $26.00 | $129,996 | Form 4 |
| Jun 11, 2026 | Timothy MahoneyDirector | Sold | 5,000 | $26.35 | $131,727 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 2 of 9 | 3 of 9 | 4 of 9 |
| Rule of 40 | −279.0% | −64,472.1% | — |
| Altman Z'' | −23.83 | −16.82 | −12.02 |
| Accruals ratio | 21.4% | −60.8% | −12.1% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Fail | Fail | Fail |
| Return on assets rose | Pass | Fail | Pass |
| Cash from operations exceeds net income | Fail | Pass | Pass |
| Debt fell relative to assets | Fail | Pass | Fail |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Fail | Fail | Pass |
| F-score | 2 of 9 | 3 of 9 | 4 of 9 |
Compare
Put Rythm side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Rythm | FY25 | 95,916.7% | −187.1% | — | −74.2% | — | 4 | |
| Reed's | FY25 | −10.2% | −44.5% | −50.8% | — | — | — | Compare |
| Zevia PBC | FY25 | 4.0% | −7.3% | −3.1% | — | — | — | Compare |
| Vita Coco | FY25 | 18.2% | 13.5% | 6.4% | 55.3% | −2.4x | 5 | Compare |
| National Beverage | FY26 | −1.7% | 19.5% | 13.2% | 65.5% | −1.4x | 7 | Compare |
6 years of figures
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 12 | 60 | 58 | 15 | 0 | 17 |
| Revenue growth | — | 395.2% | −2.7% | −74.0% | −99.9% | 95,916.7% |
| Gross profit | 1 | 5 | −32 | 4 | −0 | 10 |
| Research and development | 3 | 4 | 8 | 2 | 1 | — |
| Operating income | −13 | −35 | −193 | −13 | −5 | −32 |
| Net income | −22 | −32 | −188 | −19 | −42 | −33 |
| Diluted EPS (US$) | −79.80 | −25.35 | −13,532.85 | −187.64 | −40.92 | −16.68 |
| Diluted shares (millions) | 0 | 0 | 0 | 0 | 1 | 2 |
| Cash flow | ||||||
| Cash from operations | −15 | −30 | −72 | −31 | −12 | −24 |
| Capital expenditure | 0 | 2 | 8 | 0 | 0 | — |
| Free cash flow | −15 | −32 | −80 | −31 | −12 | — |
| Dividends paid | 1 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 1 | 36 | 4 | 0 | 0 | 0 |
| Stock-based compensation | — | 0 | 4 | 3 | 1 | 2 |
| Balance sheet at fiscal year end | ||||||
| Cash and short-term investments | 8 | 57 | 11 | 0 | 31 | 32 |
| Debt incl. finance leases | 13 | 0 | 0 | 16 | 10 | 81 |
| Total assets | 22 | 182 | 70 | 45 | 54 | 107 |
| Total liabilities | 28 | 45 | 79 | 60 | 26 | 94 |
| Shareholders' equity | −7 | 137 | −9 | −15 | 28 | 13 |
| Margins and ratios | ||||||
| Gross margin | 4.7% | 8.7% | −54.6% | 26.5% | −394.4% | 59.0% |
| Operating margin | −104.4% | −58.6% | −331.8% | −86.0% | −28,183.3% | −187.1% |
| Net margin | −178.8% | −54.2% | −323.0% | −123.2% | −231,922.2% | −192.4% |
| Free cash flow margin | −123.4% | −54.1% | −137.6% | −204.9% | −64,372.2% | — |
| Rule of 40 (growth + FCF margin) | — | 341.2% | −140.3% | −279.0% | −64,472.1% | — |
| Return on capital | — | −69.6% | −498.1% | — | — | −74.2% |
| Return on equity | — | −49.8% | −294.5% | — | −624.0% | −161.8% |
| Return on assets | — | −31.9% | −149.5% | −32.5% | −84.1% | −41.4% |
| Net debt to EBITDA | — | — | — | — | — | — |